Physician profile
Michael Jack
NPI 1780080812
$1,498.12
in general payments reported to CMS, 2019-2025
18 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.48 · 2020: $53.12 · 2021: $157 · 2022: $106 · 2023: $158 · 2024: $563 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Travel and Lodging: $39.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.87 |
| Travel and Lodging | $39.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $708.98 | 2021-2025 | Puraply, Puraply Wound Matrix, Puraply Am |
| Mimedx Group, INC. | $204.10 | 2024 | |
| Smith+Nephew, INC. | $134.76 | 2020-2025 | Collagenase Santyl, Grafix Pl |
| Integra Lifesciences Corporation | $75.36 | 2019-2025 | Tcc-Ez |
| Cashflow Solutions, LLC | $45.57 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Polynovo North America LLC | $41.60 | 2025 | Novosorb Btm |
| Hartmann USA, INC. | $40.10 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Solventum Corporation | $38.05 | 2024 | Activ.A.C. Ion Progress, Activ.A.C. |
| Dynasplint Systems INC. | $33.40 | 2021 | |
| Tactile Systems Technology INC | $28.91 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Paratek Pharmaceuticals, INC. | $23.95 | 2025 | Nuzyra |
| Stryker Corporation | $23.80 | 2019 | |
| Urgo Medical North America, LLC | $19.62 | 2024 | Urgoclean Ag |
| Kci USA, INC. | $19.20 | 2020 | |
| Abbvie INC. | $19.15 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $15.21 | 2019 | |
| Amgen INC. | $14.67 | 2024 | Krystexxa |
| Bioventus LLC | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.